The biotechnological potential of whey by Ryan, Michael P. & Walsh, Gary
 1 
 Title: The biotechnological potential of Whey  1 
 2 
Authors: Michael P Ryan* and Gary Walsh 3 
 4 
Authors address: Industrial Biochemistry Program, Chemical and Environmental Science 5 
Department and Materials and Surface Sciences Institute, University of Limerick, Limerick City, 6 
Ireland. 7 
 8 
*Corresponding Author:  9 
Department of Chemical and Environmental Sciences 10 
University of Limerick 11 
Limerick 12 
Ireland 13 
Tel:  +353 61 202448 14 
Fax: +353 61 202568 15 
E-mail: michaelpryan1983@gmail.com  16 
 17 
Keywords: whey, biotechnology, ethanol, bioconversion 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
Manuscript Click here to download Manuscript Whey Paper-Ryan and
Walsh Mini Review.docx
Click here to view linked References
 2 
Abstract 1 
Whey is a highly polluting by-product of cheese and casein powder manufacturing with 2 
worldwide production of whey is estimated at around 190×106 ton/year and growing. Historically 3 
whey was considered a burdensome, environmentally damaging by-product. In the last decades 4 
however, much research has gone into finding viable alternatives for whey rather than just 5 
disposing of it. Multiple biotechnological avenues have been explored and in some cases 6 
exploited to turn this waste product into a valuable commodity. Avenues explored include 7 
traditional uses of whey as both an animal and human food to the more advanced uses such as 8 
the use of whey protein as health promoters and the potential of whey to be used as a feed stock 9 
to manufacture a whole range of useful substances e.g. ethanol.  10 
1. What is Whey? 11 
Whey is a yellow-green liquid by-product from the manufacture of cheese or casein from milk. 12 
The yellowish colour of whey is due to the presence of riboflavin (Vitamin B2) in the whey (De 13 
Wit, 2001). The type of whey depends upon the processing technique used to remove casein 14 
from the milk, with the two main types being sweet whey and acid whey. The first type is sweet 15 
whey. Sweet whey has a pH of approximately 5.6 and comes from the production of most types 16 
of cheese or certain casein products. The first step in making cheese (and sweet whey) is the 17 
addition of rennet, a mixture of enzymes containing the protease chymosin, to milk. The rennet 18 
works by curdling the casein protein in the milk leading to the formation of curds. The curds are 19 
then strained from the remaining liquid. This is called whey. The rennet induced coagulation of 20 
casein occurs at pH 6.5 (Panaser et al., 2007, Figure 1). The other type of whey is acid whey, 21 
which has a pH of approximately 4.5. This type of whey is created by either the activity of 22 
lactobacilli or the addition of organic (lactic acid) or mineral acids (hydrochloric or sulphuric 23 
acid) to coagulate the casein for the manufacture of most types of industrial caseins (Jelen, 2003, 24 
Figure 1).   25 
Whey represents 85%-95% of the milk volume and retains about 55% of the milk nutrients (Siso, 26 
1996).  Approximately 20% of the total protein content of the milk is retained in the whey 27 
(Walsh, 2014). The main constituents of both sweet and acid whey are water (~93% of the total 28 
whey volume), lactose (C12H22O11, 70%-72% of the total solids), whey proteins (8%-10% of the 29 
total solids, these will be discussed below) and minerals (12%-15% of the total solids). Calcium, 30 
potassium, sodium and magnesium salts make up the bulk of these minerals (of >50% NaCl and 31 
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KCI, calcium salts) with trace amounts of metals such as zinc and copper (Venetsaneas et al., 1 
2009). The two whey types differ in mineral content, the pH and in the composition of the whey 2 
protein fraction (Jelen, 2003). Whey also contains small quantities of other components like 3 
lactic and citric acids, non-protein nitrogen compounds (urea and uric acid) and B group 4 
vitamins (Kosikowski, 1979, Marwaha and Kennedy, 1988). The chemical make-up of whey can 5 
vary depending on which species the milk came from. The composition of whey proteins can be 6 
seen in Table 1. 7 
2. Environmental Issues associated with whey  8 
The main problem associated with whey comes from its potential to damage the environment. It 9 
has a very high Biochemical Oxygen Demand (BOD) that can vary from 40,000-60,000 mg/L 10 
and a very high Chemical Oxygen Demand (COD) of between 50,000-80,000 mg/L 11 
(Chatzipaschali and, Stamatis 2012). The waste load of whey is equivalent to that of 100-175 12 
times that of a similar volume of domestic waste water (Mockaitis et al., 2006, Smithers, 2008). 13 
This high polluting potential makes disposal of surplus whey expensive. Lactose, the largest 14 
constituent of whey (70%–72% of the total solids), is the main component causing these high 15 
values for BOD and COD (Jelen, 2003, Patel and Murthy, 2011). 16 
Whey is created in near equal volumes to the processed milk used during cheese manufacture. 17 
Worldwide production of whey is estimated at around 190×106 ton/year (Baldasso et al., 2011). 18 
It has been shown that, for every 1 kg of cheese made approximately 9 L of whey is produced 19 
(Kosikowki, 1979). On average across the world, volumes of whey are growing at about the 20 
same rate as milk volumes (>2% per year; Smithers, 2008).  21 
From the 1960s and 70s onwards, community action groups, environmental regulatory agencies 22 
and dairy processors alike came to recognise and highlight the environmental damage being 23 
triggered by the disposal of untreated whey (Smithers, 2015). Disposal of whey by dumping in 24 
water bodies is now prohibited in most dairy producing nations by strict environmental 25 
legislation. Whey can have highly deleterious effects on aquatic life (in 2008 a spillage of acid 26 
whey in a waterbody in Ohio in the US killed more than 5400 wild animals, mostly fish [Hirsch, 27 
2015]) within the water body due to the depletion of the dissolved oxygen leading to 28 
eutrophication. This can also cause bad odours.  29 
Land spreading for the disposal of whey can lead to the build-up of compounds (salts) in the soil 30 
that can damage the soil and effect the growth of plant life (Kosikowki, 1979). Crop kills have 31 
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been reported due to the high application of cheese whey leading to rapid consumption of 1 
oxygen in the soil from the breakdown of milk sugars and proteins present in whey. Application 2 
of whey can also reduce soil redox potential. This can lead to the solubilisation of Fe and Mn 3 
present in the soil potentially contaminating ground water supplies. It has also been reported that 4 
for each mm (103 /ha) of whey applied to the soil, about 400-600 kg of total salt per hectare was 5 
added which resulted in high soil salinity and reduced crop yield (Ghaly et al, 2007). Acid whey 6 
is polluting not only the whey itself but also due to the low pH (~4.5) levels which can damage 7 
the soil. 8 
Biological wastewater treatment technologies both aerobic (including trickling filters, aerobic 9 
lagoons, activated sludge systems, membrane bioreactors and jet loop membrane bioreactor) and 10 
anaerobic can assist in safe disposal of whey within the environmental specifications, but these 11 
treatments can be expensive. Older aerobic systems have difficulty dealing with the high 12 
polluting load of the whey (requiring high dilution ratios and long retention times [Rivas et al., 13 
2010]) and large amounts of waste sludge are created which must also be disposed of (Prazeres 14 
et al, 2012). Anaerobic systems have the benefit of being able to take very high COD loads and 15 
of producing biogas that can be used for heating or powering plant process (Chatzipaschali and 16 
Stamatis, 2012). However these systems are not suitable for all climates, can be difficult to run 17 
and maintain and may need the addition of other feed stocks. 18 
3. Whey as Biotechnological Resource 19 
Whey is an excellent source of functional proteins and peptides, lipids, vitamins, minerals, and 20 
lactose that could be exploited by the agri-food, biotechnology, medical, and related industries 21 
and in the last several decades major research efforts have seen whey and whey proteins 22 
transformed from ‘gutter-to-gold’ (Smithers, 2008). 23 
3.1. Traditional uses of Whey  24 
Traditionally whey (in an unmodified form) was used as an animal feed (pigs, sheep, cattle) or 25 
was land spread as a fertiliser (Watson et al., 1977). As a direct animal feed whey (usually 26 
diluted with drinking water) provides high-quality proteins and lactose as energy sources and 27 
also provides calcium, phosphorus, sulphur and water-soluble vitamins. Excessive lactose and 28 
minerals however can cause issues for farm animals that necessitate a limit in untreated whey use 29 
as an animal feed (Sienkiewicz & Riedel, 1990). There are also issues with land spreading as the 30 
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application of large quantities of whey leaves high saline deposits in the soil, damaging fertility 1 
(Kosikowki, 1979). Both uses have difficulties concerning volumes and high transportation costs 2 
that make these solutions impractical for the amounts of whey being created today. 3 
3.2. Whey as a human food? 4 
Whey can be used to make human food products such as whey cheese and beverages. The most 5 
common whey beverages are fruit juices that have been mixed with whey (the brands Djoez and 6 
Taksi from the Netherlands and Nature’s Wander from Sweden) (Kosikowski 1968, Holsinger et 7 
al., 1974, Jelen, 2009).  An example of a carbonated soft drink is Rivella which has been 8 
manufactured and sold in Switzerland since the early 1950’s. This is made from carbonated 9 
whey permeate (discussed below) flavoured with the extract of various herbs (Pesta et al., 2007). 10 
These products however have so far failed to spread outside their home markets (Jelen, 2009).  11 
Whey can also be used to create alcoholic drinks such as a low alcoholic beverage (<1% alcohol 12 
content) (Sienkiewicz and Riedel, 1990), whey beer (Sienkiewicz and Riedel, 1990), whey wine 13 
(Jeličić et al., 2008) and whey champagne (Sienkiewicz and Riedel, 1990). Creation of these 14 
products involves addition of certain additives including sucrose and malt and the fermentation 15 
of the mixture with yeasts such as Kluyveromyces fragilis or Saccharomyces lactis (Holsinger et 16 
al., 1974). 17 
Whey can also be used to create whey cheeses with there being two main types: Ricotta or 18 
Mysost. To make Ricotta cheese the whey is heated to >80°C and the whey protein is denatured. 19 
This denatured protein then clumps (often aided by citric acid addition) forming whey protein 20 
curds that are then processed into cheese (Pintado et al., 2001). Mysost type cheeses are based on 21 
the condensation of the whey under controlled conditions. The collected whey condensate is then 22 
heated to 95°C and processed into cheese (Jelen and Buchheim, 1976). Whey butter is another 23 
potential food product that can be created from whey. Whey cream is removed from whey after 24 
cheese making and before it is processed for spray drying or protein concentration. Whey butter 25 
has been found to be slightly softer than normal butter but has a saltier flavour (Jinjarak et al., 26 
2006). These products however all have limited commercial appeal and do not present a way to 27 
treat large qualities of whey waste. 28 
Whey proteins also have uses in the food industry as their physical properties allow them to act 29 
as emulsifiers, gelling agents/ water binders and foaming/whipping agents in food systems. They 30 
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are in used in many different foods including soups, salad dressings, processed meat, dairy and 1 
bakery products (Walsh 2014). 2 
3.3. Creation of whey powders and whey permeate  3 
To create whey powders, the whey is spray dried (Kosikowski, 1979; Yang and Silva, 1995). 4 
This allows the quality of the whey to be preserved for a longer period of time for transportation 5 
or further manipulation (Siso, 1996). This type of whey powder is mostly used for animal 6 
feeding (mixed with molasses or soya flour) in the form of dairy nuts. Smaller quantities are used 7 
in human foods like ice-creams, baked goods, cakes, sauces, etc. (Siso 1996).  8 
For the manufacture of higher grade whey protein powders, the whey undergoes membrane 9 
separation by ultrafiltration or diafiltration. Whey can be treated to give three different whey 10 
protein powder types: whey protein concentrate, whey protein isolate, and the third type whey 11 
hydrolysate (Figure 2). Whey Protein Concentrate (WPC) contains levels of protein of 12 
approximately 35-80% with low, medium and high protein powders being available. Whey 13 
Protein isolate (which can also be created by ion-exchange) has a high level of protein (>90% 14 
protein) and is almost totally devoid of lactose and fats.  Whey hydrolysate is created by the 15 
enzymatic hydrolysis of WPC or WPI. The creation of WPC/WPI leaves a secondary liquid 16 
stream, whey permeate, as a residue (Mollea et al., 2013). Whey permeate has nearly as high a 17 
BOD as whole raw whey fluid, and therefore poses a troublesome disposal problem. A 18 
generalised overview of this process can be seen in Figure 2. 19 
3.4. Whey as health promoter  20 
Whey and whey derived bioactive compounds (Whey Protein Concentrate/isolate, peptides, etc.) 21 
have undergone research for their ability to enhance general health and well-being (Shah 2000, 22 
Cross and Gill 2000, Beaulieu et al., 2006, Krissansen 2007). The potential health benefits of 23 
whey have long been recognised. Whey has been used since at least the 17th century to treat a 24 
variety of conditions such as sepsis, wound healing, and ‘stomach disease’ (Hoffmann, 1961). 25 
Whey proteins have shown a variety of positive effects both nutritional and physiological. These 26 
include (A) improvements in physical performance, better recovery following exercise, and to 27 
aid in the prevention of muscular atrophy (Ha & Zemel, 2003; Ohr, 2004; Tipton et al., 2004), 28 
(B) improved weight management and appetite control (Ohr, 2004; Zemel, 2004, Schaafsma, 29 
2006a,b), (C)  improvements in cardiovascular health (Murray and FitzGerald, 2007), (D) anti-30 
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cancer effects (Bounous et al., 1991, Bounous, 2000), (E) help with the  management of 1 
infections (Bounous et al., 1993; Playford et al., 1999; Regester & Belford, 1999), (F) improve 2 
infant nutrition (Jost et al., 1999), and (G) healthy aging (Yang et al., 2012). Some of these 3 
effects are reputed but a number have undergone substantial scientific examination and they have 4 
been corroborated in numerous laboratories globally. 5 
3.4.1. Whey proteins/peptides  6 
Whey protein is considered a high quality protein sources as it contains high levels of all 7 
essential amino acids, and has a biological value (measure of the proportion of absorbed protein 8 
from a food which becomes incorporated into the proteins of the organism's body) that is 15 % 9 
greater than the former benchmark egg protein (Ismaila and Gub, 2010).  10 
Whey proteins are heat labile (Fox and McSweeney, 1998; Walstra et al., 2005). The main types 11 
of whey proteins are β-lactoglobulin (β-Lg), α-lactalbumin (α-La), bovine serum albumin (BSA) 12 
and immunoglobulins (IGs) (Table 1). BSA is found in low levels in bovine milk and this is 13 
thought that the protein leak through from blood serum. IGs are antibodies that are created in 14 
response to specific antigens and their purpose is to provide immunological protection to the 15 
young mammal. IGs are large glycoproteins (proteins with sugar moieties attached) and are heat 16 
labile in the presence of other whey proteins (Walstra et al., 2005).  17 
Miscellaneous whey proteins include lactoferrin and several different enzymes including 18 
lysozyme, oxidoreductases, phosphatases, lactoperoxidase, lipolytic enzymes and proteinases. 19 
(Table 1, Walstra et al., 2005).   20 
Creation of casein curds using rennet produces a fragment k-casein molecule that is called 21 
glycomacropeptide (GMP) and this peptide ends up in the whey. The GMP constitutes 22 
approximately 15% of the whey protein fraction of sweet, rennet-based wheys, but is not present 23 
in the acid whey (Lim et al., 2007, Neelima et al, 2013) 24 
Bioactive peptides are derived from whey proteins by enzymatic hydrolysis using pancreatic 25 
enzymes such as trypsin and chymotrypsin or the stomach enzyme pepsin these enzymes usually 26 
come from bovine or porcine sources (Madureira et al., 2010) or from bacterial, fungal or yeast 27 
proteases (Morais et al., 2014). Some bioactive peptides can also be created through microbial 28 
fermentation of whey protein. For example Lactobacillus helveticus fermentation of whey 29 
proteins creates an angiotensin I-converting enzyme inhibitory (ACE) peptide (Yamamoto et al., 30 
1999). Different whey derived peptides are listed in Table 1. 31 
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Whey has also been found to contain several growth factors including insulin-like growth factor, 1 
platelet-derived growth factor, transforming growth factor, and, fibroblast growth factor (Pouliot, 2 
and Gauthier, 2006). These growth factors could be potentially used as a reliable replacement 3 
for, or as a supplement to fetal bovine serum (Smithers et al., 1996). Fetal bovine serum is used 4 
in mammalian cell culture, used in the manufacture of vaccines and biopharmaceuticals. The use 5 
of a whey derived growth factor media would provide a cheaper and safer alternative to fetal 6 
bovine serum that would not be at risk of contamination from mycoplasma, viruses and Bovine 7 
Spongiform Encephalopathy (BSE) (Keenan et al., 2006). 8 
3.5. Lactose 9 
Milk sugar lactose (4-O-β-D-galactopyranosyl-D-glucose) can be recovered from cheese whey or 10 
more likely from whey permeate by crystallization (Patterson, 2009). 11 
Lactose is used widely within the food and confectionery industries due to its low sweetness 12 
(16% that of sucrose [Joesten et al., 2006]). It is used in the baking industry to promote crust 13 
browning through the Maillard reaction. It is also added to cow’s milk (4.4 - 5.2% in bovine milk 14 
compared to 7% in human milk) in the preparation of infant formula. Lactose is also used in the 15 
pharmaceutical industry as an excipient (Patterson, 2009). The amounts of lactose produced from 16 
whey have increased greatly since the 1940’s (Sienkiewicz & Riedel, 1990). 17 
Lactose can also be used for the direct production of various other compounds. Lactulose (4-O-18 
β-D-galactopyranosyl-D-fructose) is a lactose derivative that has several potential uses. It can 19 
also be used as a sweeter. Lactulose has an advantage in this use as it is more soluble than lactose 20 
which makes it easier to use in food applications and it also has a greater sweetness value (48-21 
62% of sucrose [Parrish et al. 1979]) (Mizota et al. 1987). It can be used as a sweetener for 22 
diabetics, as a substitute for sucrose in confectionery products, as an additive in milk/dairy 23 
applications, and in various foods (liquid or dry) that are made for the elderly (Mayer et al., 24 
2004). It can also be used as a laxative in the treatment of acute and chronic constipation 25 
(Tramonte et al. 1997), and also in the treatment of hyperammonemia (excess of ammonia in the 26 
blood) and chronic hepatic encephalopathy (impairment of brain function due to liver issues) 27 
(Blanc et al. 1992). More recently, it has been considered for use as a prebiotic (De Souza 28 
Oliveira et al. 2011). It is created via an alkaline isomerization of lactose however research has 29 
been undertaken on enzymatic synthesis of the compound (Aider and Halleux, 2007, Tang et al. 30 
2011). 31 
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Lactitol (4-O-(β-galactopyranosyl)-D-sorbitol) is a sugar alcohol used as a replacement bulk 1 
sweetener for low calorie foods, slimming products and in foods specially formulated for 2 
diabetics with ~ 40% of the sweetness of sucrose. It has been investigated as a potential prebiotic 3 
due to the fact that it can be metabolised to short chain fatty acids by the colonic microbiota 4 
(Dills, 1989). Lactitol, like lactulose, can also be used to treat constipation and chronic hepatic 5 
encephalopathy (Patil et al., 1987, Faruqui and Joshi, 2012).  Lactitol is created by the chemical 6 
hydrogenation of lactose (Zacharis, 2012).   7 
Lactosylurea ([4-O-β-D-galactopyranosyl-1 - N- β -o-glucopyranosyl] urea) is another potential 8 
lactose derivative. This can be used as a non-protein nitrogen source in ruminant feeding. It has 9 
major advantages over other non-protein nitrogen sources such as urea, as due to the slow 10 
breakdown of the product no toxic ammonia level is reached (Yang and Silva, 1995). No product 11 
of yet is commercially available.  12 
Another potential use of the lactose present in whey permeate is to hydrolyse the lactose into 13 
glucose and galactose. This can be achieved by immobilised β-Galactosidase. Hydrolysed lactose 14 
solutions have greater sweetening power than lactose (glucose has 80% and galactose 60% of the 15 
relative sweetness of sucrose [Joesten et al., 2006] ) and have applications in the confectionery, 16 
ice-cream and soft drink industries, potentially replacing saccharose or corn starch syrup (Gänzle 17 
et al., 2008). The sweetness of the hydrolysed lactose solution can be increased by the 18 
conversion of the glucose present after hydrolysation of the lactose to fructose (110% of the 19 
relative sweetness of sucrose) with glucose isomerase (Moulin & Galzy, 1984; Kosaric & Asher, 20 
1985). 21 
Lactose from whey can also be used in the creation of Galactooligosaccharides (GOS). These are 22 
prebiotics that can have a positive effect on human health by encouraging the growth of probiotic 23 
bacteria in the gut. They are frequently produced from lactose in a reaction catalysed by β-24 
galactosidase, termed transglycosylation or they can be produced chemically (Torres et al., 25 
2012). GOS’s are made from a variable number (2-8) of galactose units linked to a terminal 26 
glucose. They can be created from the lactose present in whey (Jovanovic-Malinovsk et al., 27 
2012, Golowczyc et al., 2013). 28 
3.6. Bioconversion of Whey into useful products 29 
Significant efforts are being undertaken worldwide to find ways to upgrade surplus whey to a 30 
feed stock for bioconversion towards various value-added products. Lactose (present in whey 31 
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permeate), as the major carbohydrate component of whey, can act as a carbon source for growth 1 
and product formation in numerous biotechnological processes. In the literature, the production 2 
of bioethanol (Ghaly & El-Taweel, 1997; Zafar & Owais, 2006), vinegar (Parrondo et al., 2009), 3 
antibiotics, such as the bacteriocin nisin, (Liu et al., 2005), yeasts for yeast extract production (de 4 
Palma Revillion et al., 2003) and baker’s yeast (Champagne and Goulet, 1988), surface active 5 
compounds (surfactants) like sophorolipids (Daniel et al., 1999), single-cell protein (Schultz et 6 
al., 2006), “green bioplastics” like Polyhydroxyalkanoates, PHAs, (Ahn et al., 2000; Ahn et al., 7 
2001; Kim, 2000; Povolo & Casella, 2003; Koller et al., 2007 a,b), and lactic acid as both a 8 
“green bioplastic” in the form of polylactic acid (PLA) and as an important as food additive 9 
(E270) and in  pharmaceutical use (Wee et al., 2006) are all due to the bioconversion of lactose 10 
/whey.  11 
3.6.1. Single Cell Protein/Yeast 12 
Single-cell protein (SCP) refers to sources of mixed protein that are extracted from either pure or 13 
mixed cultures of algae, yeasts, fungi or bacteria. These are grown on agricultural wastes. They 14 
are used as a substitute for protein-rich foods, in human and animal feeds (Anupamaa and 15 
Ravindra 2000). The production of SCP can be carried out by the fermentation of whole whey or 16 
whey permeate via direct use of lactose by microorganisms or of hydrolysed lactose (hydrolysed 17 
by enzymatic or chemical means) (Boze et al., 1995). Lactose can be converted directly into 18 
biomass by numerous microorganisms. Much of these studies have been done with lactose 19 
utilizing yeasts, mostly K. fragilis or Kluyveromyces marxianus strains, which offer advantages 20 
of good growth yields and are GRAS (Generally Regarded As Safe) microorganisms (Mahmoud 21 
and Kosikowski, 1982, Willetts and Ugalde 1987, Ghaly et al., 2005, Anvari and Khayati, 2011). 22 
3.6.2. Ethanol 23 
Whey permate  is an attractive as a feed source for the creation  of ethanol as it is a polluting by-24 
product that can be used instead of food resources (such as corn) and does not require the 25 
extensive preprocessing (high temperature acid treatments to break apart the different tyupes of 26 
cellulose) that is required for the production of ethanol from cellulose. 27 
Over the last three decades, many authors have researched the production of ethanol from lactose 28 
carried out using fermentations with yeasts such as K. fragilis, K. marxianus and Candida kefyr 29 
[formally Candida  pseudotropicalis] (Rogosa et al., 1947). Gabardo et al. (2014) reported that 30 
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cells of K. marxianus immobilised in Ca-alginate improved ethanol yield in continuous culture 1 
fermentations. The maximum value achieved was a productivity of 6.97 g/L/h; one of the highest 2 
values reported to date. 3 
The use of S. cerevisiae for lactose fermentation has also attracted much research. Intially use of 4 
S. cerevisiae involved the fermentation of pre-hydrolysed (enzymatically) lactose solutions 5 
(mixtures of glucose and galactose). However since of the advent of advance genetic 6 
manipulation techniques attempts have been made to create lactose-consuming S. cerevisiae 7 
strains. These include protoplast fusion, expression of heterologous ß-galactosidases that are then 8 
secreted to the extracellular medium or the simultaneous expression of the permease and ß-9 
galactosidase of K. marxianus. This system  operating under continuous bioreactor resulted in 10 
ethanol productivity of ~10g/L/h (Domingues et al., 2001).  However to date none of these S. 11 
cerevisiae systems have been used on an industrial basis. An excellent review covering this 12 
subject can be found in Guimarães et al., 2010. 13 
A few commercial scale processes to manufacture ethanol using whey as a fermentation feed 14 
stock have been established, with plants in Ireland, the United States, New Zealand, Denmark 15 
and Germany (Lyons and Cunningham, 1980, Pesta et al., 2007, Siso, 1996, Muller 2015). 16 
Carbery Group (Cork, Ireland) was the first company in the world to operate a whey to ethanol 17 
process on an industrial scale. This plant first opened in 1978. Until 2005 the plant produced 18 
potable ethanol (the main uses of this was for beverages, pharmaceuticals and industrial products 19 
(printing inks, etc.) but since 2005 it has supplied fuel ethanol to the Maxol oil company for E85 20 
[85% ethanol] (since withdrawn from the market [www.rte.ie/news/business/2010/1210/295386-21 
maxol/]) and E5 [5% ethanol] blends (Doyle, 2005, Ling, 2008). As of 2008, the plant operates 22 
with eleven fermentation vessels that use compressed air for mixing and aeration. The whey 23 
permeate is fermented in batches in these fermentation vessels for 12 to 20 h, depending on the 24 
initial concentration and yeast (thought to be K. marxianus) activity. The whey permeate is 25 
concentrated by reverse osmosis (from 4 to 8%) to attain higher lactose content. This is done in 26 
order to ensure a more efficient fermentation. The yeast is recovered at the end of the 27 
fermentation process. The yeast can be potentially reused a number of times before it is 28 
discarded. Ethanol levels at the end of fermentation range from 2.5–4.2% (v/v). After the 29 
fermentation is completed a continuous distillation process is used to extract the ethanol and 30 
create a product that is usable (Pesta et al., 2007 and Ling, 2008). Once completed, the yeast is 31 
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separated from the fermented substrate, and the remaining liquid (which is called beer) is sent to 1 
a distillation process to extract ethanol. This ethanol is dehydrated by use of a rectifier. Petrol is 2 
added to the ethanol if it is going to be used for fuel (to prevent any misuse). The effluent (the 3 
remaining liquid after ethanol has been removed from the beer) is sent to a waste treatment 4 
system. The yeast can be reused in the process, directly sold as animal feed, or undergo further 5 
processing to create a higher quality animal feed (Ling 2008). Carbery produces about 10.5 6 
million litres of ethanol per year (Irish Bioenergy Association 2012). 7 
In New Zealand, Anchor Ethanol, a subsidiary of the dairy processor the Fonterra Cooperative 8 
Group (New Zealand’s largest company), operates 3 plants that convert whey to ethanol (at 9 
Reporoa, Edgecumbe and Tirau). These produce around 15 million litres of ethanol per year 10 
(Anchor Ethanol, 2009). These plants use two different processes with the Reporoa plant using 11 
the Carbery process and the Tirau plant uses a continuous fermentation process (Wongso1993). 12 
The type of plant operated at Edgecumbe is not publically disclosed. These plants produce 13 
different ethanol grades, from potable ethanol for beverages to anhydrous alcohol for fuels 14 
(Thiele, 2005). The main markets for the whey derived ethanol has been pharmaceutical, 15 
cosmetics, industrial solvents (including inks) as well as the food and beverage industry 16 
(Hamilton, 1998 and Thiele, 2005). Since 2007, fuel ethanol has also been supplied to a petrol 17 
company in New Zealand for an E10 [10% ethanol] blend (Ling, 2008).  18 
The process of ethanol production varies between plants, but they all share common basic 19 
principles and steps. After whey protein has been harvested from whey by ultrafiltration, yeast 20 
can be added the whey permeate. Lactose in whey permeate is fermented by specially adapted 21 
strains of yeast (thought to be K. marxianus in the Carbery process, Streptococcus fragilis in the 22 
Dansk Gaerings process, K. fragilis in the Milbrew process) that are efficient in fermenting 23 
lactose. The yeast is added to the fermenting substrate and pumped to the fermentation vessels.  24 
The fermentation of whey permeate to create ethanol is a highly attractive prospect but as things 25 
stand it is not economically competitive when compared to ethanol production from other 26 
sources such as sugarcane, corn or lignocellulose biomass. Whey permeate to ethanol production 27 
is estimated to cost between $1.60-1.85 per gallon compared with $1.14 per gallon for ethanol 28 
from corn and $0.83 per gallon for ethanol from sugar cane [all currency U.S dollar] (Budny and 29 
Sotero, 2007, Ling 2008). 30 
 13 
Biobutanol production from whey has also been investigated. Biobutanol has advantages over 1 
ethanol such as the fact that it can be used directly in petrol engines whereas the use of ethanol 2 
requires engine modifications. Limited research using Clostridia species to transform whey into 3 
butanol has been carried out (Raganati et al., 2013, Qureshi et al., 2014). 4 
3.6.3. Bio-plastics 5 
Using whey as a raw material to create bioplastics has also become an area of investigation. 6 
Compounds such as polyhydroxyalkanoates (PHA’s) and Polylactic Acid (PLA) can be made 7 
into bioplastics through the bioconversion of the lactose present in whey permeate. These 8 
materials have many advantages when compared to traditional plastics in that they come from 9 
renewable biomass sources instead of finite petroleum oil and most, but not all, are designed to 10 
biodegrade. Common uses of bioplastics are packaging materials for food and other materials, 11 
disposable cutlery and as insulation (Chen and Patel, 2011). 12 
PHAs are polyesters (polymers that contain ester functional groups in their main chain) of 13 
various hydroxyalkanoates which are created by numerous microorganisms (Solaiman et al., 14 
2006) where they act as a carbon and energy reserve material. PHAs are synthesised when an 15 
essential nutrient such as nitrogen or phosphorus is limited but when there is an excess carbon 16 
source (Lee, 1996). Further reading about PHAs can be found in Sudesh et al., 2000. PHA’s have 17 
many potential applications in medicine such as the material for sutures, rivets, tacks, staples, 18 
screws and surgical mesh(Chen and Wu, 2005). 19 
The microbial conversion of whey lactose to PHAs can follow three possible strategies. The 20 
easiest way is through the direct conversion of lactose to PHA however only a limited number of 21 
microorganisms, such as Hydrogenophaga pseudoflava and recombinant Escherichia coli can 22 
carry out this task (both have β-galactosidase activity). Another possible way is the fermentation 23 
of the monomers glucose and galactose after the enzymatic or chemical hydrolysis of lactose. 24 
The resulting monomers, glucose and galactose, will be used by microorganisms (such as 25 
Pseudomonas hydrogenovora or Haloferax mediterranei) to produce PHAs (for strains that do 26 
not have β-galactosidase activity). The third way involves the conversion of lactose to lactic acid 27 
(via Lactobacilli) and the latter used for PHAs production (by all common PHA producers such 28 
as Alcaligenes latus) (Koller et al., 2007). 29 
Lactic Acid is created as the major metabolic end-product of carbohydrate fermentation of the 30 
Lactic Acid Bacteria (LAB) (Todar 2014). This lactic acid can be converted through 31 
 14 
condensation reactions to PLA (Södergård and Stolt, 2010). Further reading about PLAs can be 1 
found in Chen and Patel, 2011. The conversion of whey lactose to lactic acid is carried out by 2 
lactic acid bacteria.  3 
In May 2014 Cellulac became the first company worldwide to carry out a continuous industrial 4 
level production of lactic acid from deproteinised lactose whey. A 10 day production run 5 
delivered pure D-lactic acid that was suitable for conversion to bioplastics and other industrial 6 
chemicals. The system uses a whole cell non-GMO (Genetically Modified Organism) lactobacilli 7 
to transform the lactose present in the deproteinised lactose whey in d-lactic acid that was used to 8 
create polylactic acid (Cellulac, 2014). 9 
PLA (as with PHA) can be used in medical materials such as in the form of screws, plates, pins, 10 
rods, and meshes for surgery. It has also been used for producing loose-fill packaging, compost 11 
bags, compostable food packaging, and compostable, disposable tableware (cups, plates, etc.). In 12 
fibers and non-woven textiles, PLA can be used for disposable garments, awnings, feminine 13 
hygiene products, and disposable diapers (Auras et al., 2011). 14 
Other potential types of bioplastics from whey are binary bioplastics created using whey protein. 15 
Whey protein has been explored for packaging applications due to its strong oxygen barrier 16 
properties (Markus Schmid et al., 2012).  However, whey protein based bioplastics have inherent 17 
stiffness/brittleness that makes them difficult to use. To overcome this problem binary based 18 
bioplastics have been investigated. These are created by blending the whey protein with other 19 
plentiful biopolymers such as natural latex and egg white albumin (Sharma and Luzinov, 2013). 20 
This type of bioplastic can be used as recyclable food packaging (Wheylayer Project 2014). They 21 
can also be used to form edible films or coatings to improve food appearance or for preservation. 22 
They have better mechanical and barrier properties when compared with most other 23 
protein/carbohydrate based products especially when a plasticizer such as glycerol or sorbitol are 24 
added to reduce brittleness and improve the moisture resistance of the film/coating (Walsh, 25 
2014) 26 
3.6.4. Bacteriocins 27 
Bacteriocins are antimicrobial peptides that are created by both Gram positive and Gram 28 
negative bacteria that inhibit bacterial growth. They are considered to be narrow spectrum 29 
antibiotics with the spectrum of activity of the bacteriocin depending on the producing species 30 
(Chen and Hoover, 2003, Cotter et al., 2013). The positive effect of bacteriocins in different 31 
 15 
types of food including dairy, meat and fish products, fruit and vegetables has been well defined 1 
(O’Sullivan et al., 2002). Further applications are possible in the medical, pharmaceutical and 2 
veterinary fields (Jones et al., 2005). LAB’s (Lactic Acid Bacteria) are prolific in bacteriocins 3 
and are able to synthesize different classes of bacteriocins (Beshkova and Frengova, 2012). The 4 
LAB Lactococcus lactis produces nisin which is the only bacteriocin that is industrially 5 
synthesised and that has been authorised for used in food by the US Food and Drug 6 
Administration FDA (Jones et al., 2005). 7 
Nicin can be produced using (supplemented) whey as a growth media. Other bacteriocins such as 8 
pediocin (form Pediococcus acidilactici), enterocin (from Enterococcus faecalis) and a 9 
bacteriocin created by Bacillus licheniformis have also been created using a whey media (Flores 10 
and Alegre, 2001, Pérez et al., 2010, Goulhen et al., 1999, Ananou et al., 2008, Cladera-Olivera, 11 
et al., 2008). With the increasing prevalence of antibiotic resistance, bacteriocins could be a 12 
viable alternative in combatting microbial infections and whey meida could be a cheap and 13 
effective means to create these (Cotter et al., 2013). 14 
3.6.5. Enzymes 15 
Several different bacteria and yeast species have been grown on whey/whey permeate for the 16 
purpose of harvesting enzymes for possible use in industrial processes or in detergents. Enzymes 17 
include proteases, amylases, polygalacturonases (plant enzymes that are involved in the ripening 18 
process and bacterial and fungal enzymes that are involved in the rotting process) (Table 2); 19 
however most research has been directed at β-Galactosidase production. In order to achieve 20 
useable enzyme levels in the case of proteases or amylases additional nutrient supplementation is 21 
usually required. This supplement could come in the form of yeast extract, starch, amino acids or 22 
a protein such as gelatin, casein or albumin (El-Shora and Metwally, 2008). This 23 
supplementation differs with different species and even different strains of the same species.  24 
3.6.6. Organic chemicals  25 
Whey and whey permeate can be used to create several organic chemicals that can have 26 
applications in the food, pharmaceutical and chemical industries through fermentations. These 27 
fermentations are carried out by microorganisms (see Table 2) with complex biosynthesis 28 
pathways that can bio-transform the whey into a whole range of useful organic chemicals. 29 
Examples include citric acid, acetic acid (vinegar), propionic acid, glycerol, etc (Table 2).  30 
 16 
3.6.7. Bio-Hydrogen 1 
Hydrogen is a clean energy source which does not create greenhouse gases or contribute to acid 2 
rain. The use of various carbohydrate-rich wastewaters such as agricultural waste or waste 3 
cheese whey can be a feasible option for the production of bio-hydrogen (Kapdan and Kargi 4 
2006, Yang et al., 2007). Whey could be particularly useful as the fermentation of lactose could 5 
lead to a theoretical yield of 8 mol of hydrogen for every mol of lactose (Kuo et al., 2014), 6 
however to date the highest yield that has been obtained is 3 mol of hydrogen for every mol of 7 
lactose (Collet et al., 2004). The maximum amounts of hydrogen created from whole whey were 8 
2.9 L of hydrogen per litre of cheese whey (Venetsaneas et al., 2009). The biogas mixture 9 
formed in hydrogen production also contains methane (CH4) and carbon dioxide (CO2) The 10 
anaerobic fermentation necessary for hydrogen creation can be carried out by both obligatory 11 
anaerobes such as Clostridia butyricum, Clostridium pasteurianum and Clostridium beijerinkii 12 
(Ferchichi et al., 2005) or facultative anaerobes such as Enterobacter, Citrobacter sp. or E. coli 13 
(Rosales-Colunga et al., 2010). The reactions can be carried out at both mesophilic (Yang et al., 14 
2007) and thermophilic temperatures (Azbar et al., 2009). 15 
4. Conclusions 16 
With milk production rising globally each year by 2% (Smithers, 2008) and cheese production 17 
growing by 3% annually (Anon, 2014) evidence suggests that the volume of whey produced will 18 
continue to increase in the coming years. Developing sustainable methods of dealing with the 19 
whey produced is of great necessity. Outside of the enormous growth in the use of whey proteins 20 
however much work is needed to truly exploit the potential of whey. New, more efficient and 21 
economic processes and systems must be developed especially in the emerging fields of 22 
bioplastic and bioethanol production where whey can be utilized as a building block in the 23 
replacement of fossil fuels. 24 
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Table 1: Major protein constituents of whey and their (or their peptide derivatives) functions 
Protein  % of whey 
protein* 
Peptide 
Derivatives  
Potential Functions that are beneficial to human health Reference 
β-lactoglobulin 50-55 β-Lactophorin 
β-Lactotensin 
Angiotensin I converting enzyme (ACE) inhibition to lower blood 
pressure 
Appetite enhancer 
Appetite suppressant 
Welderufael et al., 2012 
α-lactalbumin 20-25 α-Lactophorin Used in infant formula 
Opioid agonist 
Increase serum levels of tryptophan to improve sleep quality cognitive 
performance under stress, and mood under stress 
Lowers blood pressure  
Sandström et al., 2008 
Antila et al., 1991 
Markus et al., 2000,2002, 2005 
 
Nurminen et al., 2000 
Immunoglobulins 10  Help protect against illness such as oral or intestinal microbial infections Hurley and Theil, 2011 
Serum albumin 5-10 Albutensin 
Serophorin 
Prevention of cancer 
Appetite suppressant 
Opioid agonist 
Laursen et al., 1989 
Ohinata et al., 2002 
Tani et al., 1994 
Proteose peptone 3 12    
Lactoferrin ~1-2 Lactoferricin Anti-microbial and anti- viral properties   
Bone Growth promoter 
Anti-Cancer Activity 
Pihlanto, 2011 
Cornish et al., 2004 
Iigo et al., 1999 
Kozu et al., 2009 
Lactoperoxidase ~0.5  Protection against microbial infection 
Prevention of dental caries 
Preservation of raw milk 
Pihlanto, 2011 
Glycomacropeptide 
(a casein pepetide) 
10-15  
(in renneted 
whey only) 
N/A Anti-thrombotic activities 
Nutritional additive in infant formula  
Used in formulating foods for suffers of Phenylketonuria 
Appetite suppressant 
Requena et al., 2004 
 
Lim et al., 2007 
Pihlanto 2011 
* Depends on the type of Whey 
 
Table Click here to download Table Table 1.docx 
Table 2: Industrially useful products that can be created use whey  
Products from 
Whey 
Use Production Commercially 
available 
products  
Organism/Process used for Bioconversion References 
Bioethanol Fuel, alcoholic 
beverages, 
chemical industry  
Fermentation of 
whey permeate 
Yes Klyveromyces lactis, Klyveromyces marxianus, recombinant 
Saccharomyces cerevisiae (Direct conversion of lactose to 
ethanol) 
Lactococcus lactis (Direct conversion of lactose to ethanol) 
S. cerevisiae (Conversion of hydrolysed lactose to ethanol) 
Guimarães et al., 2010 
Zafar and Owais, 2006 
 
 
Silva et al., 2010 
Biobutanol  Fuel, chemical 
industry 
Fermentation of 
whey 
 Clostridium acetobutylicum DSM 792, Clostridium 
saccharobutylicum  (conversion of whey to butanol) 
Raganati et al., 2013 
Qureshi et al., 2014 
Antibiotics 
(Bacteriocins) 
Food industry, 
health industry 
Fermentation of 
whey permeate 
 Lactococcus lactis (conversion of lactose [supplemented 
with  Yeast extract and casein hydrolysate] to bacteriocin- 
nisin) 
 
 
 
Pediococcus acidilactici (conversion of lactose 
[supplemented with  Yeast extract] to bacteriocin -pediocin) 
Enterococcus faecalis (conversion of lactose to bacteriocin -
enterocin) 
Bacillus licheniformis(conversion of whey to bacteriocin) 
 
Amiali et al., 1998 
Flores and Alegre, 2001 
Liu et al., 2005 
González-Toledo et al., 
2010 
Pérez et al., 2010 
Goulhen et al., 1999 
Ananou et al., 2008 
 
Cladera-Olivera, et al., 
2008 
Single Cell 
Protein 
Animal feed, 
food industry 
Fermentation of 
whey permeate 
Yes K. marxianus, K. fragilis (conversion of lactose/ hydrolysed 
lactose to biomass) 
Kefir (conversion of lactose to biomass) 
Schultz et al., 2006 
Mansour et al., 1993 
Paraskevopoulou et al., 
2003 
PHA Bioplastics Fermentation (can 
be direct or 2 
step) of whey 
permeate 
 Hydrgenophaga pseudoflava, recombinant Escherichia coli 
and Cupriavidus nector (Direct conversion of lactose to 
PHA) 
Lactobacilli (conversion of lactose to Lactic acid) followed 
Koller et al., 2007 
Ahn et al., 2000, 2001 
Povolo et al., 2010 
 
Table Click here to download Table Table 2.docx 
by C. nector (conversion of Lactic acid to PHA) 
Pseudomonas hydrogenovora, Haloferax mediterranei 
(Conversion of hydrolysed lactose to PHA) 
Lactic acid/PLA Bioplastics, food 
industry 
Fermentation (and 
chemical 
polymerisation of 
PLA) of whey 
permeate 
Pilot plant is 
operational 
Lactobacilli (conversion of lactose to Lactic acid)  
Lactic acid then converted to polylactic acid by chemical 
polymerisation 
Panesar et al., 2007, 2010 
Cellulac, 2014 
 
Glycerol Fuel, chemical 
industry 
Fermentation of 
whey permeate 
 K. fragilis (Direct conversion of lactose [supplemented with 
sodium sulfite to glycerol) 
K. marxianus (Direct conversion of lactose to glycerol) 
Aspergillus melleus, Aspergillus flavus, Aspergillus 
sclerotiorum (Direct conversion of lactose to glycerol) 
Jenq et al., 1989 
 
Rapin et al., 1994 
Zohri, 2001 
Sophorolipids Pharmaceutical, 
cosmetic, food, 
petrochemical 
industries, 
2 step 
fermentation 
 Cryptococcus curvatus (conversion of lactose to single cell 
oil) Candida bombicola (conversion of single cell oil to 
sophorolipids ) 
Daniel et al., 1999 
Otto et al., 1999 
Single Cell Oil Food and 
pharmaceutical 
industries 
Fermentation of 
whey 
 Mortierella isabellina, Thamnidium elegans, Mucor 
sp(conversion of lactose to single cell oil) 
Fusarium spp. (conversion of lactose to single cell oil) 
Vamvakaki et al., 2010 
Akpinar-Bayizit, et al., 
2014 
Citric Acid Chemical 
industry 
Fermentation of 
whey  
 Candida lipolytica (conversion of whey [supplemented with 
Date seed hydrolysate] to Citric Acid) 
Aspergillus niger (conversion of whey [supplemented with 
sucrose] to Citric Acid) 
 
Abou-Zeid et al., 1983 
 
Hossain 1983 
El-Holi and Al-Delaimy, 
2004 
 
Propionic Acid Chemical, food, 
pharmaceutical 
industry 
Fermentation of 
whey 
 Propionibacterium sp. conversion of lactose to Propionic 
Acid) 
Propionibacterium freudenreichii ssp. Shermanii (conversion 
of whey [supplemented with crude glycerol] to Propionic 
Acid) 
Propionibacterium acidipropionici (conversion of lactose to 
Colomban et al., 1993 
Kośmider et al., 2010 
 
 
 
Morales et al., 2006 
Propionic Acid) 
Gibberellic acid Agricultural uses Fermentation of 
whey permeate 
 Fusarium moniliforme (conversion of lactose to Gibberellic 
acid)  
Aspergillus niger (conversion of lactose to Gibberellic acid)  
Maddox, and Richert, 
1977 
Gohlwar et al., 1984 
Cihangir and Aksöza, 
1997 
Gluconic Acid Food, 
pharmaceutical 
industry 
Fermentation of 
whey/whey 
permeate 
 Gluconobacter oxydans (conversion of Kluyveromyces 
bulgaricus hydrolysed lactose to ethanol) 
Aspergillus niger (conversion of lactose to Gluconic Acid) 
Van Huynh et al., 1989 
 
Chaturvedi et al., 1999 
Mukhopadhyay et al., 
2005 
2,3-butanediol Manufacture of 
synthetic rubber 
and solvents 
Fermentation of 
whey/whey 
permeate 
 Bacillus polymyxa (conversion of whey to 2,3-butanediol) 
 
Klebsiella pneumoniae (conversion of lactose to 2,3-
butanediol) 
Enterobacter aerogenes (conversion of whey to 2,3-
butanediol) 
Speckman, and Collins, 
1982 
Lee and Maddox, 1984, 
1986 
Perego et al., 2000 
Succinic acid Chemical 
industry 
Fermentation of 
whey 
 Anaerobiospirillum succiniciproducens (conversion of whey 
to Succinic acid) 
Actinobacillus succinogenes (conversion of whey to Succinic 
acid) 
 
Lee et al., 2000 
 
Wan et al., 2008 
Lactobionic acid Cosmetics, 
pharmaceutical 
industry, medical 
industry 
Fermentation of 
whey 
 Pseudomonas taetrolens (conversion of whey to Lactobionic 
acid) 
 
Alonso et al., 2013 
Vinegar 
(acetic acid) 
Food industry 2 step 
fermentation of 
whey permeate 
 K. marxianus (conversion of lactose to ethanol) Acetobacter 
pasteurans/Gluconoacetobacter liquefaciens (conversion of 
ethanol to acetic acid) 
Parrondo et al., 2009 
Enzymes  Washing 
detergents, 
industrial 
processes  
Fermentation of 
whey 
 K. marxianus, Candida pseudotropicalis, Lactobacillus 
delbrueckii subsp. Bulgaricus,  Streptococcus thermophiles, 
Aureobasidium pullulans (β-galactosidase) 
 
 
Bacillus sp (α-amylase) 
Aspergillus niger, Aspergillus terreus, Serratia marcescens 
(proteases) 
 
K. fragilis (Endo-Polygalacturonase) 
 
 
 
 
Rao and Dutta, 1977 
de Bales and Castillo, 
1979 
Vasiljevic and Jelen, 2001 
Kaur et al., 2015 
Bansal et al., 2008 
Bajpai et al., 1991,1992 
El-Shora, and Metwally, 
2008 
Romero et al., 2001 
Gomez-Ruiz, et al., 1998 
Donaghy  and McKay, 
1994 
Kaur et al., 2015 
 
 
 
 
 
 
 
